Arcellx (ACLX) Non-Current Deffered Revenue (2021 - 2025)

Arcellx (ACLX) recorded quarterly Non-Current Deffered Revenue of $53.1 million in Q4 2025, up 1.28% quarter-over-quarter from $52.4 million in Q3 2025, and down 30.13% on a YoY basis from $76.0 million in Q4 2024.

Arcellx (ACLX) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends

Arcellx's Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $53.1 million for Q4 2025.

  • In Q4 2025, Non-Current Deffered Revenue fell 30.13% year-over-year to $53.1 million; the TTM figure through Dec 2025 stood at $53.1 million (down 30.13% YoY), while the FY2025 annual figure was $53.1 million, down 30.13% from the prior year.
  • Non-Current Deffered Revenue was $53.1 million for Q4 2025 at Arcellx, up from $52.4 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $170.7 million in Q4 2023 to a low of $1.9 million in Q4 2021.
  • Historically, Non-Current Deffered Revenue has averaged $86.6 million across 4 years, with a median of $82.6 million in 2024.
  • Biggest YoY gain for Non-Current Deffered Revenue was 5.96% in 2024; the steepest drop was 55.47% in 2024.
  • A 4-year view of Non-Current Deffered Revenue shows it stood at $1.9 million in 2021, then jumped by 8906.49% to $170.7 million in 2023, then slumped by 55.47% to $76.0 million in 2024, then sank by 30.13% to $53.1 million in 2025.
  • The last three Non-Current Deffered Revenue figures came in at $53.1 million (Q4 2025), $52.4 million (Q3 2025), and $59.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - 53.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 53.10 Mn
Sep 30, 2025 52.43 Mn
Jun 30, 2025 59.92 Mn
Mar 31, 2025 69.45 Mn
Dec 31, 2024 76.00 Mn
Sep 30, 2024 82.61 Mn
Jun 30, 2024 96.08 Mn
Mar 31, 2024 112.07 Mn
Dec 31, 2023 170.67 Mn
Sep 30, 2023 121.09 Mn
Jun 30, 2023 124.27 Mn
Mar 31, 2023 105.76 Mn
Dec 31, 2021 1.90 Mn